Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Genetic Lingo01:11

Genetic Lingo

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and burden of coronary artery disease in young adults undergoing clinically indicated coronary CT angiography.

Open heart·2026
Same author

Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE Study.

Journal of the American College of Cardiology·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Blood Pressure Assessment Across the Lifespan: Improving Clinical Research and Clinical Practice: A National Heart, Lung, and Blood Institute Workshop Report.

Journal of the American College of Cardiology·2026
Same author

Concordance between Awake Blood Pressure on Home and Ambulatory Blood Pressure Monitoring in Older Adults.

American journal of hypertension·2026

Related Experiment Video

Updated: May 11, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Do Different Depression Phenotypes Have Different Risks for Recurrent Coronary Heart Disease?

Jonathan A Shaffer1, William Whang, Daichi Shimbo

  • 1Department of Medicine, Columbia University Medical Center, New York, NY.

Health Psychology Review
|May 14, 2013
PubMed
Summary

Depression increases acute coronary syndrome (ACS) risk, but standard treatments fail. Focusing on specific depression subtypes, like inflammation-induced or anhedonic depression, may identify high-risk patients and guide targeted therapies for better cardiac outcomes.

Keywords:
acute coronary syndromecardiovascular diseasesdepressiondepressive disordermyocardial infarctionphenotype

Related Experiment Videos

Last Updated: May 11, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Area of Science:

  • Cardiology
  • Psychiatry
  • Medical Research

Background:

  • Depression is linked to higher risks of acute coronary syndrome (ACS) recurrence and mortality.
  • Conventional depression interventions have not effectively mitigated this increased cardiovascular risk.

Purpose of the Study:

  • To explore intermediary depression phenotypes beyond a single complex diagnosis.
  • To identify specific depression subtypes associated with heightened risk for ACS recurrence and mortality.
  • To inform the development of targeted depression treatments for improved cardiac outcomes.

Main Methods:

  • Focusing on two intermediary depression phenotypes: Inflammation-Induced Incident Depression and Anhedonic Depression.
  • Examining the relationship between these specific phenotypes and ACS risk.
  • Proposing a new theoretical approach for depression phenotyping in cardiovascular research.

Main Results:

  • The study hypothesizes that intermediary phenotypes can better identify individuals at high risk for ACS recurrence and mortality.
  • It suggests that specific depression subtypes, unlike a general diagnosis, may be amenable to targeted interventions.
  • Further research is needed to validate these phenotypes and their association with cardiovascular outcomes.

Conclusions:

  • A phenotyping approach to depression is crucial for understanding its impact on cardiovascular health.
  • Identifying specific depression subtypes like Inflammation-Induced Incident Depression and Anhedonic Depression may lead to more effective treatments for ACS patients.
  • This research paves the way for personalized depression interventions to improve cardiac patient outcomes.